LORI GANTON: Open Payments
NPI 1528657210 · SCHOOLCRAFT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,747 in 87 payments from 22 companies in 2025. Trend: 2023 $1,217 · 2024 $1,426 · 2025 $1,747
Food & beverage: $1,747
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $480 |
| Otsuka America Pharmaceutical, Inc. | 15 | $241 |
| PFIZER INC. | 6 | $136 |
| Astellas Pharma US Inc | 4 | $82 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $75 |
| ABBVIE INC. | 5 | $74 |
| VERTEX PHARMACEUTICALS INCORPORATED | 4 | $65 |
| Boston Scientific Corporation | 3 | $63 |
| Novo Nordisk Inc | 3 | $60 |
| Novartis Pharmaceuticals Corporation | 3 | $59 |
Products named: REXULTI, FARXIGA, AIRSUPRA, NURTEC ODT, BREZTRI, Veozah, Kerendia, JOURNAVX.
Industry payments across MI — which companies pay providers there.
